Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cysteamine versus hydroquinone for post-acne hyperpigmentation
IRCT20140212016557N5Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of cysteamine and hydroquinone in Post-inflammatory hyperpigmentation (PIH) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Melanin index and Postacne hyperpigmentation index. Started Apr 2019; status: completed.
02
Drugs
cysteaminehydroquinone
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on IRCT20140212016557N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140212016557N5.